These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32328200)

  • 1. The role and function of PPARγ in bladder cancer.
    Peng T; Wang G; Cheng S; Xiong Y; Cao R; Qian K; Ju L; Wang X; Xiao Y
    J Cancer; 2020; 11(13):3965-3975. PubMed ID: 32328200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
    Vallée A; Lecarpentier Y
    Front Immunol; 2018; 9():745. PubMed ID: 29706964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
    Han EJ; Im CN; Park SH; Moon EY; Hong SH
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e239-48. PubMed ID: 23332223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer.
    Wang Q; Imam MU; Yida Z; Wang F
    Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
    Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
    Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity.
    Yousefnia S; Momenzadeh S; Seyed Forootan F; Ghaedi K; Nasr Esfahani MH
    Gene; 2018 Apr; 649():14-22. PubMed ID: 29369787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin induces the expression of peroxisome proliferator-activated receptor gamma in bladder cancer cells.
    Lodillinsky C; Umerez MS; Jasnis MA; Casabé A; Sandes E; Eiján AM
    Int J Mol Med; 2006 Feb; 17(2):269-73. PubMed ID: 16391825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of
    Cao R; Wang G; Qian K; Chen L; Qian G; Xie C; Dan HC; Jiang W; Wu M; Wu CL; Xiao Y; Wang X
    J Cancer; 2017; 8(12):2282-2295. PubMed ID: 28819432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.
    Yang C; Jo SH; Csernus B; Hyjek E; Liu Y; Chadburn A; Wang YL
    Am J Pathol; 2007 Feb; 170(2):722-32. PubMed ID: 17255338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
    Na HK; Surh YJ
    Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.
    Moldes M; Zuo Y; Morrison RF; Silva D; Park BH; Liu J; Farmer SR
    Biochem J; 2003 Dec; 376(Pt 3):607-13. PubMed ID: 12954078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of peroxisome proliferator-activated receptor-γ in breast cancer.
    Kotta-Loizou I; Giaginis C; Theocharis S
    Anticancer Agents Med Chem; 2012 Nov; 12(9):1025-44. PubMed ID: 22583414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products, PGC-1
    Suntar I; Sureda A; Belwal T; Sanches Silva A; Vacca RA; Tewari D; Sobarzo-Sánchez E; Nabavi SF; Shirooie S; Dehpour AR; Xu S; Yousefi B; Majidinia M; Daglia M; D'Antona G; Nabavi SM
    Acta Pharm Sin B; 2020 May; 10(5):734-745. PubMed ID: 32528825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
    Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
    Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ sumoylation-mediated lipid accumulation in lung cancer.
    Phan ANH; Vo VTA; Hua TNM; Kim MK; Jo SY; Choi JW; Kim HW; Son J; Suh YA; Jeong Y
    Oncotarget; 2017 Oct; 8(47):82491-82505. PubMed ID: 29137280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.